Location History:
- Delft, NL (2017)
- 's-Gravenhage, NL (2020)
Company Filing History:
Years Active: 2017-2020
Title: Teake Kooistra: Innovator in Diabetic Complications Research
Introduction
Teake Kooistra is a notable inventor based in 's-Gravenhage, Netherlands. He has made significant contributions to the field of medical research, particularly in understanding diabetic complications through innovative animal models. His work has led to the development of methods that could potentially transform therapeutic approaches to diabetes-related health issues.
Latest Patents
Teake Kooistra holds two patents that focus on animal models for studying diabetic complications. The first patent, titled "Animal model for non-alcoholic steatohepatitis and liver fibrosis," reveals a surprising discovery that low-density lipoprotein receptor-deficient mice (LDLr) fed high-energy diets exhibit controllable and consistent diabetic complications, particularly renal damage. This invention outlines a method for identifying preventive or therapeutic regimens aimed at treating diabetic micro- or macrovascular complications, with a specific focus on assessing renal damage.
The second patent, "Animal model for diabetic complications," similarly highlights the use of LDLr-deficient mice under high-energy diets to study diabetic complications. This invention also details a method for discovering preventive or therapeutic regimens, emphasizing the assessment of changes in the micro- or macrovascular systems of the animals.
Career Highlights
Teake Kooistra is affiliated with the Netherlands Organization for Applied Scientific Research (TNO), where he continues to advance research in the field of diabetes and its complications. His innovative approaches have garnered attention in the scientific community, contributing to a deeper understanding of the pathophysiology of diabetes.
Collaborations
Teake has collaborated with notable colleagues, including Robert Kleemann and Reinout Stoop. These partnerships have further enriched his research endeavors and have facilitated the exploration of new therapeutic avenues in diabetes treatment.
Conclusion
Teake Kooistra's work exemplifies the intersection of innovation and medical research, particularly in the realm of diabetic complications. His patents and ongoing research hold promise for future advancements in therapeutic strategies for diabetes.